TCL Archive Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment. July 30, 2004
TCL Archive NCOG Still Alive, But Not Without Fight On NCAB In Test Of Regional Cooperative Group Concept May 22, 1981
TCL Archive Upton Explains New NCI System: Rants Funded “Across The Board” Strictly By Priority Score August 25, 1978
